Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats

Neuroscience

Volumn 88, Issue 2, 1999, Pages 585-597

  Wang, P ^a   Barks, J D E ^a   Silverstein, F S ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

AIDS; Brain injury; Excitatory amino acids; Excitotoxicity; Newborn; NMDA

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENE PRODUCTS, TAT; HIPPOCAMPUS; HIV INFECTIONS; HIV-1; IN SITU NICK-END LABELING; MALE; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032890281     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00242-5     Document Type: Article

References (45)

1. Barks J. D., Sun R., Malinak C., Silverstein F. S. gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Expl Neurol. 132:1995;123-133.
2. Barks J. D., Liu X. H., Sun R., Silverstein F. S. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience. 76:1997;397-409.
3. Belman A. L. Acquired immunodeficiency syndrome and the child's central nervous system. Pediatr. Clin. North Am. 39:1992;691-714.
4. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
5. Choi D. W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
6. Cupp C., Taylor J. P., Khalili K., Amini S. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene. 8:1993;2231-2236.
7. Demarchi F., d'Adda A., diFagagna D., Falaschi A., Giacca M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70:1996;4427-4437.
8. Ensoli B., Barillari G., Zaki Salahuddin S., Gallo R. C., Wong-Stall F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma leions of AIDS patients. Nature. 345:1990;84-86.
9. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
10. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33:1993;429-436.
11. Epstein L. G., Sharer L. R., Joshi V. V., Fojas M. M., Koenigsberger M. R., Oleske J. M. Progressive encephalopathy in children with acquired immune deficiency syndrome. Ann. Neurol. 17:1985;488-496.
12. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
13. Gelbard H. A., James H. J., Sharer L. R., Perry S. W., Saito Y., Kazee A. M., Blumberg B. M., Epstein L. G. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropath. appl. Neurobiol. 21:1995;208-217.
14. Gendelman H. E., Lipton S. A., Tardieu M., Bukrinsky M. I., Nottet H. S. The neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 56:1994;389-398.
15. Giulian D., Wendt E., Vaca K., Noonan C. A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. natn. Acad. Sci. U.S.A. 90:1993;2769-2773.
16. Hagan P., Poole S., Bristow A. F., Tilders F., Silverstein F. S. Intracerebral NMDA injection stimulates production of interleukin-1 beta in perinatal rat brain. J. Neurochem. 67:1996;2215-2218.
17. Hayman M., Arbuthnott G., Harkiss G., Brace H., Filippa P., Philippon V., Tonson D., Vigne R., Wright A. Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus. Neuroscience. 53:1993;1-6.
18. Kolson D. L., Buchhalter J., Collman R., Hellmig B., Farrell C. F., Debouck C., Gonzalez-Scarano F. HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res. Hum. Retrovir. 9:1993;677-685.
19. Li C. J., Friedman D. J., Wang C., Meteleve V., Pardee A. B. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science. 268:1995;429-431.
20. Lipton S. A. Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 15:1992;75-79.
21. Lipton S. A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Devl Neurosci. 16:1994;145-151.
22. Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:1994;613-622.
23. Lipton S. A., Sucher N. J., Kaiser P. K., Dreyer E. B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:1991;111-118.
24. Lookeren Campagne M. V., Lucassen P. J., Vermeulen J. P., Balazs R. NMDA and kainate induce internucleosomal DNA cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain. Eur. J. Neurosci. 7:1995;1627-1640.
25. Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M., Nath A. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37:1995;373-380.
26. Maragos W. F., Silverstein F. S. The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum. Devl Brain Res. 88:1995;117-121.
27. McDonald J. W., Chen C. K., Trescher W. H., Johnston M. V. The severity of excitotoxic brain injury is dependent on brain temperature in immature rat. Neurosci. Lett. 126:1991;83-86.
28. McDonald J. W., Roeser N. F., Silverstein F. S., Johnston M. V. Quantitative assessment of neuroprotection against NMDA-induced brain injury. Expl Neurol. 106:1989;289-296.
29. McDonald J. W., Silverstein F. S., Johnston M. V. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 459:1988;200-203.
30. McDonald J. W., Silverstein F. S., Johnston M. V. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res. 490:1989;33-40.
31. McDonald J. W., Trescher W. H., Johnston M. V. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res. 583:1992;54-70.
32. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N., Geiger J. D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70:1996;1475-1480.
33. New D. R., Ma M., Epstein L. G., Nath A., Gelbard H. A. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3:1997;168-173.
34. Petito C. K., Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146:1995;1121-1130.
35. Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnott G., Metzger D., Roubin R., Filippi P. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology. 205:1994;519-529.
36. Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 239:1988;586-592.
37. Purvis S. F., Jacobberger J. W., Sramkoski R. M., Patki A. H., Lederman M. M. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retrovir. 11:1995;443-450.
38. Rasty S., Thatikunta P., Gordon J., Khalil K., Amini S., Glorioso J. C. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc. natn. Acad. Sci. U.S.A. 93:1996;6073-6078.
39. Sabatier J. M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65:1991;961-967.
40. Schneider J., Kandu O., Copeland T. D., Oroszlan S., Hunsmann G. Shedding and interspecies type seroreactivity of the envelope glycoprotein gp120 of the human immunodeficiency virus. J. gen. Virol. 67:1986;2533-2538.
41. Shi B., De Girolami U., He J., Wang S., Lorenzo A., Busciglio J., Gabuzda D. Apoptosis induced by HIV-1 infection of the central nervous system. J. clin. Invest. 98:1996;1979-1990.
42. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., Griffin D. E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
43. Wahl L. M., Corcoran M. L., Pyle S. W., Arthur L. O., Harel-Bellan A., Farrar W. L. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. natn. Acad. Sci. U.S.A. 86:1989;621-625.
44. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., Krammer P. H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
45. Yager J., Towfighi J., Vannucci R. C. Influence of mild hypothermia on hypoxic-ischemic brain damage in the immature rat. Pediatr. Res. 34:1993;525-529.